[Tamoxifen induced thromboembolic events in breast cancer. Some possible mechanisms]
{{output}}
Tamoxifen is an antagonist of the oestrogen receptor, used in the treatment of breast cancer. It is known to reduce osteoporotic bone fractures, but it increases the risk of endometrial tumors and venous thromboembolic events (VTEs). VTEs increased significant... ...
